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ABSTRACT 
34 
35 Although L-ascorbate (vitamin C) is an important biological antioxidant, its degradation 
36 pathways in vivo remain incompletely characterised. Ascorbate is oxidised to 
37 
38 dehydroascorbic acid, which can be either hydrolysed to diketogulonate (DKG) or further 
39 oxidised. DKG can be further degraded, oxidatively or non-oxidatively. Here we characterise 
41 DKG products formed non-enzymically and non-oxidatively at 20°C and at a slightly acidic 
42 
43 pH typical of the plant apoplast. 
44 
45 High-voltage electrophoresis revealed at least five products, including two novel CPLs 
46 (epimers of 2-carboxy-L-threo-pentonolactone), which slowly interconverted with CPA (2- 
48 carboxy-L-threo-pentonate). One of the two CPLs has an exceptionally low pKa. The CPL 
49 
50 structures were supported by MS [(C6H7O7)
–] and by 1H and 13C NMR spectroscopy. 
51 Xylonate and its lactone also appeared. 
52 
53 
Experiments with [1-14C]DKG showed that all five products (including the 5-carbon xylonate 
54 
55 and its lactone) retained DKG’s carbon-1; therefore, most xylonate arose by decarboxylation 
56 
57 
58 
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of CPLs or CPA, one of whose –COOH groups originates from C-2 or C-3 of DKG after a 
‘benzilic acid rearrangement’. Since CPLs appeared before CPA, a DKG lactone is probably 
the main species undergoing this rearrangement. 
CPA and CPL also form non-enzymically in vivo, where they may be useful to researchers as 
‘fingerprints’, or to organisms as ‘signals’, indicating a non-oxidative, slightly acidic 
biological compartment. 
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benzilic acid rearrangement 
carboxypentonolactones 
dehydroascorbic acid 
diketogulonate 
trihydroxypropyltartronic acid 
vitamin C degradation 
 
 
Abbreviations used: DHA, dehydroascorbic acid; DKG, 2,3-diketogulonate; CPA, 2- 
carboxy-L-threo-pentonate; CPL, 2-carboxy-L-threo-pentonolactone (either of the two 
epimers). 
 
 
1. Introduction 
 
L-Ascorbate is the major low-molecular-weight antioxidant in plant cells and an important 
antioxidant in animal cells (Smirnoff, 2018). Under aerobic conditions, ascorbate readily 
forms dehydroascorbic acid (DHA) in solution. This reaction is catalysed by the plant cell- 
wall enzyme, ascorbate oxidase (with water as by-product; Lin & Varner, 1991), and in the 
presence of minute traces of transition metal ions it also occurs non-enzymically (with H2O2 
as by-product; Khan & Martell, 1967). In vivo, DHA can be enzymically reduced back to 
ascorbate by DHA reductase, with glutathione. as reductant (Noctor & Foyer, 1998). Both 
ascorbate and DHA serve as vitamin C, important in human nutrition. Interestingly, oxidation 
of ascorbate to DHA is reported to enhance plant cell growth (Li et al., 2017). 
If DHA is not reduced back to ascorbate, then it is chemically and/or enzymically converted 
to products from which (it is generally accepted) ascorbate cannot be regenerated. There are 
two alternative routes of such irreversible vitamin C loss: under oxidising conditions, DHA is 
oxidised to oxalate plus threonate (and oxalyl-threonate esters), whereas if oxidation is 
limited, then DHA mainly undergoes hydrolysis to form 2,3-diketo-L-gulonate (DKG). DKG 
exhibits the interesting ability to inhibit amyloid protein defibrillation, suggesting that ‘loss’ 
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of ascorbate to DKG may serve beneficial roles (Yang & Zeng, 2018). DKG formation is 
thought to be irreversible in mammalian cells (Nishikawa et al., 2001), as DKG has been 
shown to have no antiscorbutic properties (Penney & Zilva, 1945). However, there is some 
evidence that DHA can be re-formed from DKG in vitro using non-biological agents such as 
aqueous hydrogen iodide (Penney & Zilva, 1945) or mercaptoethanol (Deutsch & Santhosh- 
Kumar, 1996). 
DKG itself is an unstable compound, and has been reported to form a range of other products, 
including xylosone (Kang et al., 1982; Shin & Feather, 1990), xylonate, threonate and oxalate 
(Kagawa & Takiguchi, 1962), as well as incompletely characterised compounds. Under 
‘physiological’ conditions, DKG appears to be susceptible to oxidative, reductive, and non- 
redox reactions: 
Oxidative: Oxidation of DKG leads to the formation of threonate. This can occur via two 
sequential oxidative decarboxylation reactions, with 2-oxo-L-threo-pentonate (OTP; ‘2-keto- 
L-xylonate’) as intermediate (Parsons and Fry, 2012; Dewhirst and Fry, 2018), or it can occur 
via oxalyl-threonate esters (Dewhirst and Fry, 2018). 
Reductive: Curiously, DKG (C6H8O7 in the un-ionised form) also seems to be susceptible to 
reduction, forming an ascorbate-like product (‘compound 1’ of Kärkönen et al., 2017), that 
can generate H2O2 in Picea abies (Norway spruce) cell-suspension culture and in fresh 
culture medium (Kärkönen & Fry, 2006) and can also inhibit peroxidase activity (Kärkönen 
et al., 2017). This as-yet incompletely defined compound, with the molecular formula 
C6H6O5, was demonstrated not to be compounds ‘C’ or ‘E’ as defined in the present 
manuscript (Kärkönen et al., 2017). 
Non-redox: Non-redox products are the focus of this paper. One example is erythrulose (a 
non-oxidative product if the other product is oxalate), a highly reactive ketose that has been 
suggested to play a role in cataract formation in the human lens due to its ability to crosslink 
proteins (Simpson & Ortwerth, 2000). In animal cells DKG has been shown to undergo non- 
oxidative decarboxylation to form xylonate and lyxonate (Kanfer et al., 1960; Kagawa & 
Takiguchi, 1962). These compounds can then enter the pentose phosphate pathway, 
ultimately generating glucose 6-phosphate and lactate (Bánhegyi et al., 1997). The 
production of xylonate and lyxonate from DKG has not been documented in plants. Other 
non-redox products of DKG include its lactones (3,4-diketogulonolactone and 2,3- 
diketogulonolactone), which are ene-diols that may block the oxidation of yolk lipoproteins 
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and so are potentially important for nutrition and health (Retsky et al., 1993; Li et al., 2001). 
Other C5 catabolism products with the same redox status as DKG found in animals include L- 
xylosone (Shin & Feather, 1990). A further reported non-oxidative product of DKG is the C6 
branched-chain compound, CPA (2-carboxy-L-threo-pentonate) (Löwendahl & Petersson, 
1976; Niemelä, 1987; Norman & Rose, 1987), assumed to be formed by a ‘benzilic acid 
rearrangement’ of DKG in which C-2 becomes a COOH group attached to the former C-3, 
or C-3 becomes a COOH group attached to the former C-2. CPA is the probable identity of 
‘compound E’, reported to be formed from ascorbate in the apoplast of cultured Rosa cells 
(Green & Fry, 2005; Parsons et al., 2011). 
Here we have characterised five non-redox products of DKG catabolism formed at room 
temperature in aqueous, slightly sub-pH7 solutions mimicking the plant apoplast (Green & 
Fry, 2005) and certain animal fluids such as urine, in which DKG is found (Monier & Weiss, 
1953; Koshiishi et al., 1998). Two of these products (two epimers of 2-carboxy-L-threo- 
pentonolactone; CPLs) appear to be new compounds, whose production in vivo may offer 
analytically informative clues as to the redox state of the cellular compartments in which they 
occur as well as ‘informing’ the organism of non-oxidative, non-acidic conditions. 
 
 
2. Materials and methods 
 
2.1. DKG preparation 
 
Diketo-L-gulonic acid (DKG) was prepared from commercial DHA by alkaline hydrolysis in 
a solution containing 50 mM DHA and 60 mM NaOH. The hydrolysis was stopped after 6 
minutes with a slight excess of acetic acid. The resulting solution of DKG was stored at – 
80°C. 
Such preparations of DKG contained several other compounds [including the ‘C’ and ‘E’ 
previously reported by Green & Fry (2005)]. These compounds were isolated from a 
preparation of DKG by preparative high-voltage paper electrophoresis at pH 2.0, and 
subsequent elution from the paper. 
 
 
2.2. Anion-exchange column chromatography of DKG degradation products 
237 
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A solution of freshly prepared DKG (0.5 ml, 50 mM) was passed through a 2-ml Dowex 1 
anion-exchange column [formate form; pre-washed with 4 ml each of 0.5 M NaOH, 0.5 M 
formic acid, 2 M sodium formate, 10 mM formate (pyridinium) buffer (pH 5), then 8 ml 
H2O]. Compounds were eluted with 10 × 0.5 ml H2O, 3 × 1 ml 100 mM formic acid, 3 × 1 ml 
150 mM formic acid, 3 × 1 ml 200 mM formic acid, 3 × 1 ml 250 mM formic acid, 3 × 1 ml 
300 mM formic acid, 3 × 1 ml 4 M formic acid, and 3 × 1 ml 4 M trifluoroacetic acid. All 
fractions were dried in a SpeedVac and stored at –80°C. 
 
 
2.3 High-voltage paper electrophoresis 
 
Electrophoresis was performed on Whatman No. 3 paper at 2.5–3.5 kV for 30–70 minutes in 
a buffer of pH 2.0 (formic acid/acetic acid/water, 1:4:45, v/v/v) or pH 6.5 (pyridine/acetic 
acid/ water, 33:1:300 v/v/v) (Fry, 2011). Orange G (2 µl, 10 mM) was added to all samples as 
an internal marker. Neutral compounds move a small distance away from the origin owing to 
electro-endo-osmosis. DKG and related compounds were stained with AgNO3 (Fry, 2000). 
Electrophoretograms containing 14C-labelled compounds autoradiographed on film (Kodak 
BioMax MR-1 film) for 7 days. 
For 2-dimensional paper electrophoresis, a single sample, along with external markers, was 
loaded onto Whatman No. 3 paper and subjected to electrophoresis as described above. The 
paper was then dried before the lane of interest was cut out. This lane was then sewn onto the 
origin of a new sheet of Whatman No. 3 paper, so that the compounds in the sample lane 
were lined up along the new origin. Further markers (internal marker Orange G, and external 
marker DKG products) were added. This new paper was then subjected to electrophoresis at 
either pH 2.0 or pH 6.5 as described previously. 
 
 
2.4. Mass spectrometry 
 
Samples were purified for mass spectrometry by preparative high-voltage paper 
electrophoresis followed by elution from the paper or by anion-exchange column 
chromatography. Samples were prepared at 2 µM concentration in 50:50 acetonitrile:water. 
Negative-ion electrospray ionisation mass spectrometry was carried out on a 12T SolariX 
Fourier transform ion cyclotron mass spectrometer (Bruker Daltonics). 
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2.5. Nuclear magnetic resonance spectroscopy 
 
After purification by preparative high-voltage paper electrophoresis followed by elution from 
the paper, samples were dissolved in D2O and Proton NMR spectra (500 MHz) and 13C NMR 
spectra (125 MHz) were obtained at 25°C, by use of a Bruker Avance 500 NMR 
spectrometer with a DCH cryoprobe optimised for 13C/1H observation. 
 
 
3. Results 
 
3.1. CPLs are lactones of CPA 
 
The incompletely characterised DKG metabolites ‘C’ and ‘E’ (Green & Fry, 2005; Parsons et 
al., 2011) will be shown in the present paper to be CPLs (a mixture of two epimers) and CPA 
respectively, and for consistency these names are used throughout. CPLs and CPA are 
formed non-enzymically in aqueous solution at at 20°C in slightly acidic media. The CPL 
spot was confirmed to be a lactonised form of CPA, as shown by experiments (Fig. S1) in 
which these compounds were incubated in either acid (promoting the formation of lactones) 
or alkali (promoting the hydrolysis of lactone rings) and then analysed by high-voltage paper 
electrophoresis at pH 6.5. CPL was the predominant spot during acidic incubation; alkali 
favoured CPA formation. 
 
 
3.2. CPL comprises two isomers of (C6H7O7)– 
Putative CPL, obtained by preparative electrophoresis at pH 6.5, was further purified by 
anion-exchange chromatography and checked by paper electrophoresis at pH 2.0 (Fig. S2). 
Fraction 30 was highly enriched in two compounds, proposed to be epimers of CPL (Fig. 
S3a). Mass spectrometry of fraction 30 revealed a major peak at m/z 191.0186 (Fig. S3) 
agreeing with the simulated peak (m/z 191.0197; error 5.7 ppm) for C H O –, compatible 
343 
344 
345 
with the CPLs being 2-carboxy-L-pentonolactones. 
6 7 7 
346 
347 
348 
349 
350 
351 
352 
353 
MS analysis of the compounds after further purification by electrophoresis at pH 2.0 (Fig. 1) 
supported the presence of two epimers of CPL [(C6H7O7)–; Fig. 1b,c] and also supported CPA 
as (C6H9O8) (Fig. 1d). Furthermore, Cmpd 2 gave a peak corresponding to the simulated 
peak for xylonate and/or lyxonate, (C5H9O6)1–, discussed in more detail below. 
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3.3. NMR spectroscopy 
 
CPLs have six carbons, all of which can be seen on the 13C-NMR spectrum (Fig. 2a). C-1 and 
C-2 are in the region (172–178 ppm) corresponding to carboxy groups. This is in agreement 
with the structure in Fig. 2a, which arbitrarily shows ‘C-1’ as the unsubstituted (ionisable) 
carboxy group and ‘C-2’ as the lactonised one. Epimers of CPL would have these two groups 
reversed. Since CPLs are formed non-enzymically, it is likely that the preparation is a 
mixture of the two epimers, both being lactones of CPA. 
1H-NMR spectroscopy (Fig. 2b) revealed four C–H bonds in the CPL preparation, 
corresponding to the predicted structure. 
 
 
3.4. Multiple CPA-related compounds 
 
Electrophoresis at pH 2.0 revealed that CPA and CPL samples (isolated by preparative 
electrophoresis at pH 6.5) contained at least five compounds, labelled CPA, CPL-a, CPL-b, 
Cmpd 1 and Cmpd 2 (Fig. 3a). These were individually eluted from a pH 2.0 preparative 
electrophoretogram and re-run analytically at pH 2.0 (Fig. 3b). Each compound proved 
acceptably stable during elution and re-running, migrating in the expected position (each 
accompanied by a trace of neutral material, probably including traces of soluble 
carbohydrates from the Whatman paper). Cmpd 1 was neutral, migrating to the same position 
as glucose and DHA. Cmpd 2 was slightly anionic at pH 2, co-migrating with threonate (and 
xylonate; Fig. 1a); and CPA and the CPLs were strongly anionic at pH 2 (migrating faster 
than the DKG marker). Cmpd 1 and the CPLs appeared to be lactones as they were lost on 
alkaline hydrolysis, leaving only CPA and Cmpd 2 (Fig. 3a). 
 
 
3.5. CPL-a, CPL-b and Cmpd 2 each have a single ionisable group with low, moderate and 
high pKa respectively 
Analysis by two-dimensional electrophoresis revealed some relationships between the 
compounds (Fig. 4). All the compounds were acceptably stable during electrophoresis and 
drying, as 2-D electrophoresis at pH 2.0 followed by pH 2.0 resulted in the compounds 
forming a single diagonal line (Fig. 4a). If interconversion between compounds had occurred 
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during the electrophoresis or drying then we would have seen a grid-like arrangement of 
silver-stained spots. Electrophoresis at pH 6.5 followed by pH 2.0 (Fig. 4b) and the converse 
(Fig. 4c) revealed that the spot of CPLs (‘Cmpd C’ of Green & Fry, 2005) in fact comprised 
CPL-a, CLP-b and Cmpd 2, all of which had co-migrated at pH 6.5 but were resolvable at pH 
2.0. Since carboxylic acids are almost fully ionised at pH 6.5, these three compounds are 
concluded to possess the same constitution (~5–6 C atoms and one negative group, i.e. ‘C5 1– 
’ or ‘C6 1–’ compounds). The proposed structure of CPLs as defined in Fig. 2 has two 
possible epimers (2-carboxy-L-xylonolactone and 2-carboxy-L-lyxonolactone), and it is likely 
that the spots labelled CPL-a and CPL-b are these two epimers. At pH 6.5, CPA migrates 
faster than the CPLs (Green & Fry, 2005), as expected since CPA is a C6 2– compound 
whereas the CPLs are C6 1– compounds, which led to the conclusion that CPL is a lactonised 
form of CPA (Green & Fry, 2005). It is interesting that at pH 2.0, the lactone CPL-a migrates 
faster than the non-lactone CPA (e.g. Fig. 3), even though they possess 1 and 2 potentially 
ionisable groups respectively. Therefore, at pH 2.0, CPL-a carries a larger total negative 
charge than CPA, indicating that the single ionisable –COOH group of CPL-a has an 
exceptionally low pKa. The third C5–6 1– product, Cmpd 2, despite approximately co- 
migrating with the CPLs at pH 6.5, had a much lower mobility at pH 2.0, indicating that it is 
a weak acid (high pKa) such as xylonate and/or lyxonate. 
 
 
3.6. CPL-a and CPL-b are lactones of CPA, and Cmpd 1 is a lactone of Cmpd 2 
 
All five compounds were purified by preparative electrophoresis, and each was treated with 
NaOH or HOAc (Fig. S4). As previously observed, CPL-a forms CPA on alkali treatment. 
CPL-b underwent similar changes. Furthermore, CPA formed faint spots of CPL-a and CPL- 
b in response to acidic treatment. The results confirmed that the CPLs and CPA are 
interconvertible: an acidic medium promoted the formation of the CPLs, whereas alkali 
(which hydrolyses lactones) promoted CPA formation. Similarly, alkali appeared to convert 
the non-ionic Cmpd 1 to the weakly acidic Cmpd 2, whereas acid converted Cmpd 2 to Cmpd 
1, indicating that Cmpd 1 is a lactone of Cmpd 2. 
 
 
3.7. All five CPA-related products retain carbon-1 of the precursor DKG 
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Radiolabelled CPA (prepared from [1-14C]ascorbate via [1-14C]DKG) provided more insight 
into the non-oxidative degradation pathway of DKG (Fig. 5). Treatment of [14C]CPA with 
acid yielded all five expected radiolabelled compounds. These corresponded to the five 
AgNO3-stained compounds seen on previous electrophoretograms, demonstrating that each 
compound retained the 14C atom from C-1 of the original ascorbate molecule. This is as 
expected for CPA and the CPLs since they still contain all six carbons originating from the 
[14C]ascorbate. 
Cmpd 2 had a migration pattern similar to that of threonate (e.g. Fig. 3b). We hypothesised 
that Cmpd 2 would have a similar constitution — for example xylonate and its epimer 
lyxonate are reported degradation products of ascorbate (presumably formed via DKG) 
(Kanfer et al., 1960). As small aldonic acids with one negative charge, xylonate and lyxonate 
would be expected to have an electrophoretic mobility similar to that of threonate. When 
Cmpd 2 was electrophoresed with internal or external marker xylonate (Fig. S5), they co- 
migrated, supporting the identification of Cmpd 2 as xylonate and/or lyxonate. 
Cmpd 2 (although presumed to be a C5 compound, having lost one carbon of the CPLs or 
CPA, probably as CO2) was also visible among the radiolabelled compounds (Fig. 5); thus at 
least some of the Cmpd 2 molecules also retained the 14C atom that originated from C-1 of 
the precursor ascorbate molecule. The same applied to neutral Cmpd 1, which is an important 
observation as a radiolabelled spot cannot be a contaminating carbohydrate eluted from the 
Whatman paper. One possible identity for this neutral compound could be a di-lactone of 
CPA; however, Cmpd 1 did not yield any detectable CPA after alkaline hydrolysis (Fig. S4), 
so this identity is unlikely. More probably, Cmpd 1 would be one or both of the the 
pentonolactones, xylonolactone and lyxonolactone, formed by decarboxylation of CPLs. This 
is supported by the observation that alkaline hydrolysis of Cmpd 1 yielded Cmpd 2 (Fig. S4). 
 
4. Discussion 
 
4.1. Occurrence and structures of DKG catabolites 
 
We have further characterised the non-oxidative, non-enzymic degradation pathway of DHA, 
via DKG, as it occurs under slightly acidic conditions mimicking the plant apoplast (Fig. 6). 
This includes identification of CPA and CPLs, previously termed compounds ‘E’ and ‘C’ 
(Green & Fry, 2005; Parsons et al., 2011). 
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CPA [described as ‘2-(threo-1,2,3-trihydroxypropyl)tartronic acid’, and presumed to be 
formed via DKG] had previously been identified as a degradation product of DHA in near- 
neutral (pH 7.4) and alkaline aqueous solutions (Löwendahl & Petersson, 1976); and its 
production in alkali was confirmed (Niemelä, 1987). In the presence of Cu2+, DKG was also 
rearranged to CPA at pH 1–14, and at pH 1–7 the CPA became sequestered as an insoluble 
crystalline complex with Cu2+ (Norman & Rose, 1987). The possible role of traces of 
apoplastic Cu2+ in generating CPA/CPL in vivo would be of interest in future studies. 
The formation of the lactones characterised by us as CPLs has apparently not been previously 
reported. In prior studies of DKG degradation in alkaline environments, any lactones would 
have been quickly hydrolysed. Indeed, Parsons et al. (2011) reported that, under the slightly 
acid conditions typical of the plant apoplast (and human urine), CPLs are formed first; CPA 
may have been generated mainly by subsequent hydrolysis of the lactones. CPL and CPA are 
interconvertible as shown in Fig. 6. 
The formation of CPLs is proposed to occur via a ‘benzilic acid rearrangement’ of the vicinal 
diketone group of DKG. This type of rearrangement is named after the reaction by which 
benzil [(PhCO)2] is converted to benzilic acid (2,2-diphenyl-2-hydroxyacetic acid) (Fig. 6, 
inset); it also occurs during saccharinic acid formation when a reducing sugar is treated with 
alkali (Collins & Ferrier, 1995). If, in vivo, the CPLs are formed first (Parsons et al., 2011), it 
seems likely that the -lactone of DKG is the main species that undergoes the benzilic acid 
rearrangement under our slightly acidic conditions, removing one carbon from the 6- 
membered ring to leave a 5-membered ring comprising a mixture of the two epimeric - 
lactones (Fig. 6). 
The two epimers of CPL were well resolved by electrophoresis at pH 2.0 (Figs. 1, 3, 4, 5 and 
S4); however, it is not clear which epimer would have the lower pKa. 
CPA and/or the CPLs are also subject to decarboxylation, forming simple pentonates and 
their lactones. Decarboxylation of one of the two CPL epimers would yield xylonate, whereas 
the other would give lyxonate. Xylonate and lyxonate have previously been identified in 
animals as ascorbate catabolites (Kanfer et al., 1960; Kagawa & Takiguchi, 1962; Shin & 
Feather, 1990). Xylonolactone is a precursor of xylonate in bacteria (Buchert & Viikari, 
1988). We detected xylonate and/or lyxonate by silver staining; they also retained at least 
some of the radioactivity originating from [1-14C]DKG. A CPL molecule, formed directly 
from [1-14C]DKG -lactone, would retain all the 14C within the ring, with the former C-2 or 
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C-3 becoming the new free –COOH group. If a [14C]CPL molecule formed in this way 
underwent decarboxylation by losing its free –COOH group, then the xylonolactone or 
lyxonolactone formed would retain all the 14C. On the other hand, if [14C]CPL delactonises to 
[14C]CPA, and then undergoes decarboxylation by losing one of its two free –COOH groups, 
then the xylonate or lyxonate formed will retain only about half the original radioactivity 
since one of the two –COOH groups is now radioactive. Either way, radioactivity of the 
[14C]DKG would be retained in the simple pentonic acids and their lactones though possibly 
with a lower specific radioactivity (Bq µmol1). 
Any xylonate/lyxonate formed by direct decarboxylation of [1-14C]DKG would be 
completely non-radioactive, since all the 14C would then have been in the single carboxy 
group, lost upon decarboxylation. We therefore conclude that the simple 14C-pentonic acids 
detected arose via intermediary CPA and/or the CPLs and not directly from DKG. 
In vivo, with [14C]DHA as substrate, [14C]CPL was found to be produced before [14C]CPA, 
with the yield of both being maximal under non-oxidising conditions which favour the 
production of [14C]DKG rather than [14C]oxalyl threonates (Parsons et al., 2011). CPL is a 
stable end-point of DHA catabolism in vivo (Parsons et al., 2011). The equilibrium in plant 
cell culture media favours the production of CPL over CPA as it is a slightly acidic 
environment. However, DKG is present in blood (Koshiishi et al., 1998), whose pH is 
typically 7.4 and so the equilibrium in this system may promote the formation of CPA. 
The current study was conducted in vitro, primarily in a buffer (acetate, pH 4.5) mimicking 
the plant apoplast, so it is likely that the reported compounds are formed in vivo; indeed CPL 
and CPA have been detected in the apoplast of cultured Rosa cells (Cmpds C and E of Green 
& Fry, 2005). However, more work will be required to definitively establish the presence of 
these degradation products in intact plants and animals. 
 
 
4.2. Biological relevance 
 
The present work shows that CPA and CPL can be generated from DKG non-enzymically 
under slightly sub-pH7 conditions in vitro. They have been also shown to form non- 
enzymically in vivo in both animals (CPA; Löwendahl and Petersson, 1976) and plants (CPA 
and CPL; Green & Fry, 2005). They may therefore be useful to researchers as ‘fingerprints’, 
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and equally to the organisms in which they occur as ‘signals’, indicating a non-oxidative, 
non-acidic biological milieu. 
It has previously been shown in living Rosa cell-suspension cultures at pH 6, that 360 µM 
apoplastic ascorbate is 90–95% degraded within 9 h, extracellularly, generating ~30–40 µM 
CPL + CPA plus other by-products(Fig. S1 of Parsons et al., 2011). The rates of formation of 
CPL + CPA were similar in (i) freshly prepared sterile culture medium, (ii) whole Rosa 
cultures, (iii) Rosa culture filtrate and (iv) heat-denatured Rosa culture filtrate — indicating 
that the reaction is largely non-enzymic. This appreciable yield of CPL + CPA observed in 
Rosa cultures indicates the biological prevalence of these compounds. 
As fingerprints, it is relevant that CPA and CPL are relatively stable in vivo, for example 
persisting for >8 hours in Rosa cell cultures (Parsons et al., 2011), which suggests that their 
presence could be a lasting indicator of prior non-oxidising and sub-pH7 conditions within 
the organism. Likewise, Löwendahl and Petersson (1976) suggest that as CPA is formed in 
blood from DHA there could be a medical significance. 
Biologically, CPA and CPL could potentially signal to the cell that it is not under oxidising 
stress and so can downregulate ascorbate production. Under oxidising conditions, DHA is 
principally oxidised to oxalyl threonates; only when oxidation is not prevalent does DHA 
persist long enough (in slightly sub-pH7 solutions) for hydrolysis to predominate and for the 
DKG thus formed to be further metabolised via the non-oxidative reactions reported in the 
present manuscript. 
In more acidic solutions, the formation of CPA and CPL is not favoured. Therefore, a further 
possibility is that CPL and CPA formation signals that the biological compartment is less 
acidic than normal. Relative alkalinisation of the apoplast (favouring CPL and CPA 
production) is a signal of drought stress (Harting et al., 1988; Pignocchi & Foyer, 2003), to 
which it is valuable for the organism to be attuned. 
 
 
5. Conclusion 
 
It is well known that ascorbate can be degraded, via DKG, to DKG. However, the 
downstream fate of DKG remains incompletely characterised. In this work, we have 
characterised five DKG products, formed non-oxidatively and non-enzymically in media at 
slightly acidic pH. Novel products in this category include two epimers of 2-carboxy-L-threo- 
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pentonolactone (CPL); their free acid (CPA) was also detected. CPLs and CPA can be further 
decarboxylated to xylonate and/or lyxonate. Although in the present work these reactions 
were monitored in vitro, in the absence of enzymes, it appears very likely that the products 
are also formed in vivo, especially in biological compartments of a slightly acidic pH and 
where ROS are not so active that DKG is quickly oxidised by in competing pathways. We 
propose that CPLs and CPA can serve as ‘fingerprints’ (valuable analytically) and signals 
(valuable to the organism), reporting a cell’s redox and pH status. 
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Fig. Legends 
 
Figure 1: Mass spectrometry of DKG degradation products purified by anion-exchange column 
chromatography. 
CPL and CPA-related compounds were separated by anion-exchange column chromatography with 
elution in increasing concentrations of formic acid (Fig. S2), and portions of the fractions containing 
the putative xylonic acid and CPL(fractions 27 and 30 respectively) were checked qualitatively by 
electrophoresis at pH 2.0 (a). 
CPL-a, CPL-b, CPA and Cmpd 2, further purified by preparative electrophoresis at pH 2.0 were 
analysed using mass spectrometry. The measured spectra are shown above the simulated spectra for a 
compound with the formula (C H O )– for CPLs (b and c), (C H O )– for CPA (d) and (C H O )- for 
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Abbreviations: CPA, 2-carboxy-L-threo-pentonate; CPL, 2-carboxy-L-threo-pentonolactone; DHA, 
dehydroascorbic acid; DKG, diketogulonate; EryR, erythrarate (meso-tartrate); ThrR, threarate (L- 
tartrate); XylO, xylonate. 
 
 
Figure 2: 
13
C and 
1
H NMR spectra of CPL. 
A purified sample of CPL (fraction 30 of Fig. S2) was analysed by 
13
C NMR spectroscopy (a) and by 
1
H NMR spectroscopy (b; expanded carbohydrate region). Inset: proposed structure. 
 
 
Figure 3: At least three additional compounds accompany CPA and CPL-a. 
 
(a) A preparation of CPA was incubated with 0.1 M NaOH or 0.2 M acetic acid (HOAc) for 16 h 
before being neutralised and run by electrophoresis at pH 2.0. 
(b) The five compounds present in the CPA sample were separated by preparative electrophoresis, 
eluted from the paper in water, and re-run by analytical electrophoresis at pH 2.0. 
Abbreviations: as in Fig. 1 plus 
AA, ascorbate; Glc, glucose; OG, Orange G; OxT, oxalyl threonate. 
 
 
Figure 4: Two-Dimensional electrophoresis of CPA-related compounds. 
 
Three identical samples containing a mixture of the five CPA-related compounds were run by 
electrophoresis (left to right, as depicted) at pH 2.0 or 6.5. The marker strips from this first-dimension 
run were cut off for staining (horizontal rectangles), then the strips containing the now separated (but 
unstained) analytes were cut out and sewn onto the origin of a new electrophoretogram. The new 
papers (with a new set of markers; vertical rectangles) were run at either the same or the other pH 
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such that the analytes now moved at 90° to first direction. After this second-dimension run, the whole 
papers were stained. Orange G was present as a marker in both dimensional runs (replenished at the 
new origin for the second dimension). The permutations of 2-dimensional runs were (a) pH 2.0 then 
pH 2.0; (b) pH 6.5 then pH 2.0; and (c) pH 2.0 then pH 6.5. In (a), all stable compounds should 
appear along the diagonal (dashed white line). In (b) and (c), we have traced the path of compounds in 
the two dimensions (dashed lines). 
 
 
Figure 5: All five CPL-related compounds retain C-1 of DKG.
. 
[
14
C]CPA (derived from [1-
14
C]DKG) was incubated in 0.1 M NaOH or 0.2 M acetic acid (HOAc) for 
16 h. The samples were neutralised and re-run by electrophoresis at pH 2.0. The marker mixture 
contains a range of oxidation and hydrolysis products from [
14
C]ascorbate (Green & Fry, 2005). An 
autoradiogram is shown. 
Abbreviations: as in Figs. 1 and 3 plus: cOxT, cyclic oxalyl threonate; OTP, 2-oxo-L-threo- 
pentonate ( ‘2-keto-L-xylonate’). 
 
 
Figure 6: Non-oxidative degradation of DHA via DKG. 
 
All reactions shown are non-enzymic. DKG is produced by hydrolysis of DHA and is proposed to 
undergo a reaction (‘benzilic acid rearrangement’ of the 1,2-diketone group) to form CPA and two 
epimers of CPL. Under slightly acidic conditions physiologically mimicking the plant apoplast or 
mammalian urine, the CPLs are formed before CPA (Parsons et al., 2011), suggesting that DKG - 
lactone is the main species which undergoes the benzilic acid rearrangement, removing one carbon 
from the 6-membered ring to leave a mixture of the two epimeric -lactones. CPA and the CPLs are 
interconvertible; they are also subject to decarboxylation, forming xylonate, lyxonate and their 
lactones. The black asterisk (*) indicates the C atom which in some experiments was radioactive; grey 
asterisks imply a lower expected specific radioactivity. The classic benzilic acid rearrangement is 
shown in the lower left-hand box. 
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Titles of Supplementary Figures 
 
 
 
Figure S1: CPLs and CPA can interconvert. 
 
Figure S2: Anion-exchange purification of compound 2 and the CPLs. 
 
Figure S3. Mass spectrometry of CPLs partially purified by anion-exchange column 
chromatography. 
Figure S4: Alkali converts CPLs to CPA and converts Cmpd 1 to Cmpd 2. 
Figure S5: Cmpd 2 co-migrates with xylonic acid on electrophoresis at pH 6.5. 
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Figure S1: CPLs and CPA can interconvert. Partially purified aqueous solutions 
of CPLs and CPA were incubated for 16 h in the presence of either 0.1 M NaOH or 
0.2 M acetic acid. After incubation, the samples were neutralised with either acetic 
acid or NaOH. Products were resolved by electrophoresis at pH 6.5 and 2.5 kV for 
30 minutes, and then stained with silver nitrate. All samples contained a trace of the 
marker, Orange G, which was circled in pencil before silver-staining. 
 
Abbreviations: 
CPA, 2-carboxy-L-threo-pentonate 
CPL, 2-carboxy-L-threo-pentonolactone 
DHA, dehydroascorbic acid 
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Figure S2: Anion-exchange purification of compound 2 and the CPLs. 
A solution of DKG (50 mM, containing additional degradation products) was 
passed through a Dowex 1 anion-exchange column (formate form). 
Compounds were eluted with H2O, increasing concentrations of formic acid 
(0.1–4.0 M) and 4 M TFA. After elution and drying, the 32 collected fractions 
were redissolved in H2O, and a small portion of each was analysed by 
electrophoresis at pH 2.0 (at 2.5 kV) and stained in silver nitrate. Fractions 27 
and 30, enriched in compounds 2 and the CPLs respectively, were selected for 
further analysis. 
Abbreviations: 
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Figure S3. Mass spectrometry of CPLs partially purified by anion- 
exchange column chromatography. 
CPLs were were partially purified as in Fig. S2, and a sample of fraction 
30 was analysed by mass spectrometry. 
(a, c) Measured spectra, broad and narrow range; (b, d) simulated 
spectra for (C6H8O7)
–. 
(a) Measured for CPLs, broad range 
(b) Simulated for (C6H7O7)
–, broad range 
(c) Measured for CPLs, narrow range 
(d) Simulated for (C6H7O7)
–, narrow range 
Fig. S4 
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Figure S4: Alkali converts CPLs to CPA and converts Cmpd 1 to Cmpd 2. 
CPA-related compounds were eluted from a prepatative electrophoretogram 
and then incubated in 0.1 M NaOH or 0.2 M acetic acid (HOAc), or with 
neither, for 4 h. After 4 h, the samples were neutralised with acetic acid or 
NaOH, spiked with orange G (internal marker), and then examined by 
analytical electrophoresis at pH 2.0 and silver-stained. 
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Figure S5: Cmpd 2 co-migrates with xylonic acid on electrophoresis at 
pH 6.5. 
A sample of Cmpd 2 (eluted from a preparative electrophoretogram) was run 
alongside a dilution series of commercial xylonic acid (XylO). A mixture of 
Cmpd 2 plus XylO was also run in one lane. The paper was subjected to 
electrophoresis at pH 6.5 and then stained with silver nitrate. 
Abbreviations: 
CPA, 2-carboxy-L-threo-pentonate 
CPL, 2-carboxy-L-threo-pentonolactone 
OG, Orange G 
XylO, xylonate 
electrophoresis pH 6.5 
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